Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update
Go back to Ultragenyx Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.29 -0.01 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $0.01 | |||
| Open | $0.30 | 52 Week Low | $0.00 | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.29 | EPS | $-0.02 | |||
| Volume | 1,929,663 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 14.65 +0.14 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.51 | 52 Week High | $117.12 | |||
| Open | $14.58 | 52 Week Low | $46.52 | |||
| Day High | $15.01 | P/E | N/A | |||
| Day Low | $14.28 | EPS | $-1.97 | |||
| Volume | 5,270,161 | |||||
